China is the bigger Brain Cancer Diagnostic market: $121 Mn against $27 Mn in 2023, about 4.4 times as large.
India grows faster: 16.6% a year, against 15.1%. The gap still grows from $93 Mn to $365 Mn by 2033.
Clinical research: 264 active trials in China, 18 in India.
| Measure |  China |  India |
|---|---|---|
| Market size, 2023 | $121 Mn | $27 Mn |
| Market size, 2033 projected | $492 Mn | $127 Mn |
| Growth a year (CAGR) | 15.1% | 16.6% |
| Money added, 2023–2033 | $372 Mn | $99 Mn |
| Share of the world market | 8% | 1.8% |
| Size rank of 24 countries | #2 | #12 |
| Market per person, 2023 | $0.09 | $0.02 |
| Active clinical trials | 264 | 18 |
| Full report | China report | India report |
Year by year, 2023 to 2033
China India · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Brain Cancer Diagnostic, China or India?
China is the bigger Brain Cancer Diagnostic market: $121 Mn against $27 Mn in 2023, about 4.4 times as large.
Which grows faster in Brain Cancer Diagnostic, China or India?
India grows faster: 16.6% a year, against 15.1%. The gap still grows from $93 Mn to $365 Mn by 2033.
More Brain Cancer Diagnostic comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.